The HealthTech 250 is Galen Growth’s selection of the 250 most promising
early-stage Digital Health ventures across the globe in 2022
All HealthTech Alpha subscribers can access the full HealthTech 250 most promising early-stage Digital Health venture list for 2022 and market maps here (New to HealthTech Alpha? Create your free account here). You can hover and click on the image to enlarge and to download the map.
Since 2017, Galen Growth has tracked and reported on the Digital Health innovation across the globe. HealthTech Alpha’s unmatched data, intel and insights allow us to uniquely assess, identify and showcase the most promising early stage Digital Health ventures in the world. Leveraging over 250 million data points and our proprietary venture signals analytics, we are proud to announce our HealthTech 250 – The Most Promising Early Stage Digital Health Ventures in 2022 and to share with you our data and analysis on each venture.
The ventures are located across the 5 largest regions for Digital Health – North and South America, Asia Pacific, Europe and the Middle East. All ventures provide solutions across the entire patient journey from prevention to reimbursement, including wellness solutions, digital therapeutics, omics related solutions, research, and clinical trial support.
Using our proprietary platform HealthTech Alpha, the largest aggregator for Digital Health ventures with more than 12,500 ventures globally, we have developed a selection algorithm that ranked the ventures based on indices, including our proprietary Alpha Score, recent partnerships, news sentiment, clinical strength, key team members, regulatory approvals and clinical strength. The market maturity and total volume of ventures within the key geographies were taken into account to generate a weighted distribution of ventures.
Click on view all ventures (bottom of the table) to open the entire HealthTech 250 as a venture matrix in HealthTech Alpha. (If you are new to HealthTech Alpha and don’t have a login, create one for free here.)